Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label rollover extension study of vemurafenib in BRAF V600 mutation-positive malignancies
2012-003144-80Phase 4Completed
- Sponsor
- Roche
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vemurafenib in Nonhematologic neoplasms, cancer, sponsored by Roche. Started Dec 2012; status: completed.
02
Drugs
vemurafenib
03
Conditions
Nonhematologic neoplasmscancer
Beyond the preview
Go deeper on 2012-003144-80.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003144-80.